LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
Copenhagen University Hospital
Copenhague, DinamarcaPublicaciones en colaboración con investigadores/as de Copenhagen University Hospital (6)
2024
-
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials
Nature Communications, Vol. 15, Núm. 1
-
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a randomized, double-blind phase 2 study
BMC Cancer, Vol. 23, Núm. Suppl 1
2020
-
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
British Journal of Cancer, Vol. 123, Núm. 5, pp. 793-802
2012
-
Randomized phase III study comparing paclitaxel/cisplatin/ gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC intergroup study 30987
Journal of Clinical Oncology, Vol. 30, Núm. 10, pp. 1107-1113
2008
-
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II
European Urology, Vol. 53, Núm. 3, pp. 497-513
-
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
European Urology, Vol. 53, Núm. 3, pp. 478-496